Single-Blind, Randomized Study of the Comparative Drug Likeability and Pharmacokinetics of Vyvanse and ADDERALL XR When Administered as a Solution.

Trial Profile

Single-Blind, Randomized Study of the Comparative Drug Likeability and Pharmacokinetics of Vyvanse and ADDERALL XR When Administered as a Solution.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2015

At a glance

  • Drugs Lisdexamfetamine (Primary) ; Mixed amfetamine salts (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 07 Apr 2009 Planned end date changed from 1 Oct 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Actual patient number (3) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top